Literature DB >> 10869547

The active-site residue Cys-29 is responsible for the neutral-pH inactivation and the refolding barrier of human cathepsin B.

J Song1, P Xu, H Xiang, Z Su, A C Storer, F Ni.   

Abstract

Human cathepsin B, the most abundant lysosomal cysteine protease, has been implicated in a variety of important physiological and pathological processes. It has been known for a long time that like other lysosomal cysteine proteases, cathepsin B becomes inactivated and undergoes irreversible denaturation at neutral or alkaline pH. However, the mechanism of this denaturation process remains mostly unknown up to this day. In the present work, nuclear magnetic resonance spectroscopy was used to characterize the molecular origin of the neutral-pH inactivation and the refolding barrier of human cathepsin B. Two forms of human cathepsin B, the native form with Cys-29 at the active site and a mutant with Cys-29 replaced by Ala, were shown to have well-folded structures at the active and slightly acidic condition of pH 5. Surprisingly, while the native cathepsin B irreversibly unfolds at pH 7.5, the C29A mutant was found to maintain a stable three-dimensional structure at neutral pH conditions. In addition, replacement of Cys-29 by Ala renders the process of the urea denaturation of human cathepsin B completely reversible, in contrast to the opposite behavior of the wild-type cathepsin B. These results are very surprising in that replacement of one single residue, the active-site Cys-29, can eliminate the neutral-pH denaturation and the refolding barrier. We speculate that this finding may have important implications in understanding the process of pH-triggered inactivation commonly observed for most lysosomal cysteine proteases.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10869547     DOI: 10.1016/s0014-5793(00)01644-6

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  5 in total

1.  Metastability of papain and the molecular mechanism for its sequential acid-denaturation.

Authors:  Rosa Eréndira Fosado-Quiroz; Arturo Rojo-Domínguez
Journal:  Protein J       Date:  2011-03       Impact factor: 2.371

2.  Polymerization of the SAM domain of MAPKKK Ste11 from the budding yeast: implications for efficient signaling through the MAPK cascades.

Authors:  Surajit Bhattacharjya; Ping Xu; Mukundan Chakrapani; Linda Johnston; Feng Ni
Journal:  Protein Sci       Date:  2005-02-02       Impact factor: 6.725

3.  Selective Neutral pH Inhibitor of Cathepsin B Designed Based on Cleavage Preferences at Cytosolic and Lysosomal pH Conditions.

Authors:  Michael C Yoon; Angelo Solania; Zhenze Jiang; Mitchell P Christy; Sonia Podvin; Charles Mosier; Christopher B Lietz; Gen Ito; William H Gerwick; Dennis W Wolan; Gregory Hook; Anthony J O'Donoghue; Vivian Hook
Journal:  ACS Chem Biol       Date:  2021-08-20       Impact factor: 4.634

4.  S-Nitrosylation of cathepsin B affects autophagic flux and accumulation of protein aggregates in neurodegenerative disorders.

Authors:  Ki-Ryeong Kim; Eun-Jung Cho; Jae-Won Eom; Sang-Seok Oh; Tomohiro Nakamura; Chang-Ki Oh; Stuart A Lipton; Yang-Hee Kim
Journal:  Cell Death Differ       Date:  2022-04-24       Impact factor: 12.067

Review 5.  The Role of Cysteine Peptidases in Hematopoietic Stem Cell Differentiation and Modulation of Immune System Function.

Authors:  Milica Perišić Nanut; Urša Pečar Fonović; Tanja Jakoš; Janko Kos
Journal:  Front Immunol       Date:  2021-07-15       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.